title: The changing timetable for the evaluation of new products for formulary consideration.
abstract: The time for drug manufacturers to educate MCOs about new drugs is not a month before obtaining Food and Drug Administration approval. Today, as Dr. Giaquinta explains, it is imperative that pharmaceutical companies present information about their pipeline products three to five years before drug launch.
authors.forename: Diane
authors.initials: D
authors.lastname: Giaquinta
mesh_terms: D004282:Documentation; D017277:Drug Approval; D004341:Drug Evaluation; D004345:Drug Industry / Q000592:standards*; D005569:Formularies as Topic; D006801:Humans; D008329:Managed Care Programs; D013995:Time; D014481:United States